Document Type

Patent

Publication Date

August 2014

Patent Number

8815260

Abstract

A method for treating or inhibiting artery obstructive disease, such as restenosis after angioplasty and stenting procedures and stenosis after coronary artery bypass surgery, in a subject by administering to the subject a therapeutically effective amount of dasatinib or a derivative thereof. Also provided are drug-eluting medical devices, including stents, having a therapeutically effective amount of dasatinib.

Application Number

13/273,731

Assignees

University of South Florida H. Lee Moffitt Cancer Center and Research Institute, Inc.

Filing Date

10/14/2011

Primary/U.S. Class

424/400

Share

COinS